Seems fair to me to ask that these agencies be transparent about their reasoning and methodology.

After all, the healthcare ratings of doctors usually have more to do with cost than anything else.

Cheaper doctor = better doctor in their eyes.

Same with drug and device ratings.

The UK Court’s logic is crystal clear. If you are going to deny or approve, your methodology must stand up to scrutiny. Otherwise, NICE simply becomes an august equivalent of the magic 8 ball.